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Abstract 
We recently found block of NO synthase in rat middle cerebral artery caused spasm, associated with 
depolarizing oscillations in membrane potential (Em) similar in form but faster in frequency (circa 
1Hz) to vasomotion. T-type voltage-gated Ca2+ channels contribute to cerebral myogenic tone and 
vasomotion, so we investigated the significance of T-type and other ion channels for membrane 
potential oscillations underlying arterial spasm.  Smooth muscle cell membrane potential (Em) and 
tension were measured simultaneously in rat middle cerebral artery. NO synthase blockade caused 
temporally coupled depolarizing oscillations in cerebrovascular Em with associated vasoconstriction. 
Both events were accentuated by block of smooth muscle BKCa. Block of T-type channels or 
inhibition of Na+/K+-ATPase abolished the oscillations in Em and reduced vasoconstriction.  
Oscillations in Em were either attenuated or accentuated by reducing [Ca2+]o or block of KV, 
respectively. TRAM-34 attenuated oscillations in both Em and tone, apparently independent of 
effects against KCa3.1. Thus rapid depolarizing oscillations Em and tone observed after endothelial 
function has been disrupted reflect input from T-type calcium channels in addition to L-type 
channels, other depolarizing currents appear to be unimportant. These data suggest that combined 
block of T and L-type channels may represent an effective approach to reverse cerebral vasospasm. 
 
Key words: cerebral vasospasm; K-channels; T-type calcium channels; nitric oxide; endothelial 
cell dysfunction 
 
 2
1. Introduction 
 
Cerebral arteries operate in a dynamic state of partial constriction (myogenic tone), providing the 
capacity to constrict or relax in response to changing levels of intraluminal pressure, shear stress 
and nerve activity. Myogenic tone is an intrinsic property of the smooth muscle, helping maintain 
constant total cerebral blood flow and adapting blood flow locally to meet metabolic demand.. 
Myogenic constriction is driven primarily by membrane depolarization leading to Ca2+ influx 
(Davis et al., 1999; Hill et al., 2001), possibly with a contribution via stretch-activated calcium 
sensitization (Schubert et al., 2008). Myogenic tone is often superimposed by vasomotion in the 
form of synchronised oscillations in smooth muscle cell membrane potential (Em), Ca2+ and tension. 
Although the physiological function of vasomotion in general is unclear, it may help to maintain a 
constant blood supply in many tissues, including the brain (Haddock et al., 2005).  
 
One key influence of basal NO release in the middle cerebral artery appears to be suppression of 
both myogenic tone (Golding et al., 2001; Peng et al., 1998; Zimmermann et al., 1997) and 
vasomotion (Dirnagl et al., 1993; Haddock et al., 2002). This influence appears largely due to 
activation of BKCa (Mandala et al., 2007; Yuill et al., 2010). So block of NO generation and/or 
BKCa provides a means to mimic an aspect of endothelial dysfunction that is an early feature of 
cardiovascular disease, including disease conditions that predispose to vasospasm  (Jewell et al., 
2004; Vanhoutte et al., 2009). These conditions will also mimic the loss of NO observed after 
subarachnoid haemorrhage, where scavenging of NO by haemoglobin (Martin et al., 1985) causes 
profound vasospasm (Toda et al., 1991).  Significantly, enhanced vasomotion (or vasospasm) can 
lead to a reduction of cerebral capillary blood flow and thus compromise of neuronal function 
(Biswal et al., 1996; Pluta, 2005).  
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Several mechanisms, including the rho-kinase pathway, can contribute to the development and 
maintenance of constriction in smooth muscle, alongside calcium entry. However, in many vascular 
beds, including the cerebral vasculature changes in smooth muscle intracellular Ca2+ ([Ca2+]i) 
concentration are critical for myogenic tone and vasomotion (Haddock et al., 2002; Haddock et al., 
2005; Yuill et al., 2010). [Ca2+]i increase involves release from intracellular stores and entry from 
the extracellular space via voltage-gated Ca2+ channels and non-selective cation channels, such as 
transient receptor potential channels (TRPC). Ca2+ influx through voltage-gated Ca2+ channels 
(VGCC) leads to global increases in smooth muscle cell [Ca2+]i and constriction, and high voltage 
activated (L-type) Ca2+ channels appear central in this sequence (McCarron et al., 1997; Moosmang 
et al., 2003; Nelson et al., 1990). These channels are expressed widely in vascular smooth muscle 
and their open probability increases over a physiologically relevant range (circa -50 to -30 mV) 
(Lacinova, 2005; Smirnov et al., 1992). Low voltage activated or T-type Ca2+ channels are also 
expressed in vascular smooth muscle of resistance arteries (Braunstein et al., 2008; Clozel et al., 
1997; Kuo et al., 2008; Navarro-Gonzalez et al., 2009; Perez-Reyes, 2003). But although they are 
normally active in the range circa  -60 to-40 mV, the characteristic rapid inactivation of these 
channels argues against a significant role  at physiologically relevant membrane potentials in the 
vasculature. Despite this, they have been implicated in the maintenance of vascular tone in a variety 
of arteries, including rat cremaster (VanBavel et al., 2002), rat basilar (Navarro-Gonzalez et al., 
2009) and middle cerebral (Lam et al., 1998) arteries, and direct measurements have shown high 
voltage-activated but nifedipine-insensitive Ca2+ currents, pharmacologically indistinguishable from 
T-type currents, in both guinea-pig and rat terminal mesenteric arteries (Morita et al., 1999; Morita 
et al., 2002). 
 
We recently reported that middle cerebral arteries develop intense and sustained constriction, 
associated with a very rapid form of vasomotion, when NOS and/or BKCa channels were blocked, to 
mimic endothelial dysfunction. Furthermore, both constriction and vasomotion depended on 
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calcium entry via VGCCs and the oscillations in Em were temporally linked to changes in smooth 
muscle [Ca2+]i (Yuill et al., 2010). The temporally linked oscillations in Em, [Ca2+]i and tension 
were similar to the widely described phenomenon of vasomotion, but displayed a much higher 
frequency (~1Hz as opposed to ~0.1-0.2Hz, Yuill et al., 2010). The intense “vasospastic 
vasomotion” was reversed by inhibition L-type Ca2+ channels and clearly involved a complex 
action of NO that appeared to include stimulation of BKCa channels and a cGMP-independent 
closure of VGCCs (Yuill et al., 2010).  However, although a central role for VGCC, NO and BKCa 
was apparent, the importance of other ionic currents that might contribute to the rapid depolarizing 
oscillations was unclear. 
 
Thus, the aim of the present study was to characterize the ionic mechanisms responsible for 
rhythmic oscillations in Em and tension in rat isolated middle cerebral arteries following inhibition 
of BKCa channels and NOS. We probed channels that may lead to both depolarization (calcium, 
sodium and chloride channels) and repolarization (potassium channels). Our data suggest a novel 
role for both smooth muscle T-type Ca2+ channels and several potassium conductances in the both  
“vasospastic vasomotion” and the underlying maintenance of vasoconstriction.  
 
2. Materials and Methods 
2.1 Animals and tissue isolation  
Male Wistar rats (200-250 g) were killed by cervical dislocation followed by decapitation, 
following institutional guidelines for animal welfare and schedule 1 of the Animals (scientific 
procedures) Act 1986. The brain was removed and immediately placed in ice-cold Krebs solution. 
Segments of the middle cerebral artery (~2 mm long) were dissected and stored in ice-cold Krebs 
for use within 30 min, with similar size vessels used in all experimental groups 
2.2 Experimental protocols  
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Segments of middle cerebral artery (internal diameter ~150 μm) were mounted in a Mulvany-
Halpern myograph (model 400A, Danish Myotechnology) in Krebs solution containing (mM): 
NaCl, 118.0, NaCO3, 24; KCl, 3.6; MgSO4⋅7H2O, 1.2; glucose, 11.0; CaCl2, 2.5; gassed with 20% 
O2, 5% CO2 and balance N2 and maintained at 37°C. After equilibration for 20min, vessels were 
tensioned to 1-1.5mN (approximates wall tension at 60mmHg). Smooth muscle tension was 
recorded with an isometric force transducer and Powerlab software (ADI, Australia). Vessel 
viability was assessed by addition of exogenous K+ (15-55 mM, total K+ concentration); only 
vessels developing tension of ≥3 mN were used, following this Endothelial cell viability was 
assessed by the ability of the protease activated receptor 2 activating peptide; SLIGRL (20 μM) 
(Alexander et al., 2008) to relax U46619 induced tone (100 nM) by ≥ 75 %, vessels with less 
relaxation were discarded. In some experiments, endothelial cells were removed by gently rubbing 
the luminal surface with a human hair; subsequent relaxation of <15 % to SLIGRL (20 µM) was 
considered as successful removal and further abrasion often lead to damage of smooth muscle cells. 
L-NAME (100 μM), indomethacin (10 μM) and iberiotoxin (100 nM) were added throughout the 
experiment (to block NO synthase (NOS), cyclooxygenase and BKCa channels, respectively), unless 
otherwise stated. In combination, these drugs gave a robust and sustained constriction (similar to 
vasospasm), and an associated rapid vasomotion. Similar responses were recorded in each case after 
inhibition of NOS alone, but vasomotion was more variable between preparations. Indomethacin 
had no effect on oscillations, but was included in the experimental cocktail to minimize any 
potential for confounding thromboxane signaling after NOS inhibition (Benyo et al., 1998; 
McNeish et al., 2007). Recordings were assessed in the presence of: the T-type (mibefradil 100 nM 
and NNC 55-0396 300 nM) and L-type (nifedipine 1 μM) Ca2+channel blockers, the KCa channel 
blockers, apamin (KCa2.3 (SKCa), 50 nM), TRAM-34 (KCa3.1 (IKCa), 1 μM), iberiotoxin (BKCa, 
KCa1.1, 100nM) and charybdotoxin (KCa3.1, BKCa, 100 nM), the KIR channel inhibitors BaCl2 (30 
μM) and CsCl2 (10 mM),  the Na+/K+-ATPase inhibitor, ouabain (1 μM) and the voltage-gated 
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K+channel inhibitor, 4-aminopyridine (4-AP, 3 mM). Papaverine (150 μM) was added at the end of 
each experiment to assess overall tone. All blocking drugs were incubated for at least 20 min before 
data was recorded to ensure maximal effect. In most experiments smooth muscle membrane 
potential (Em) and tension were measured simultaneously as previously described, using glass 
microelectrodes (filled with 2 M KCl; tip resistance, 80-120 MΩ) to measure Em (Garland et al., 
1992). 
2.3 Data analysis and statistical procedures 
Results are expressed as the mean±s.e.mean of n animals. Tension values are given in mN (always 
per 2 mm segment) and Em as mV. During the vasospastic vasomotion Em is expressed as the mean 
Em over a random 10s period of the rapid vasomotion where possible we have also reported the size 
of the depolarizing oscillations in mV. Vasodilatation is expressed as percentage reduction of the 
total vascular tone (myogenic tone plus vasoconstrictor response induced by either U46619 or the 
combination of L-NAME and iberiotoxin, as appropriate), quantified by relaxation with papaverine 
(150 μM). Graphs were drawn and comparisons made using either Student’s t-test, or one-way 
ANOVA with Tukey’s post-hoc test using Prism software (Graphpad, USA). P≤0.05 was 
considered significant. 
2.4 Drugs, chemicals, reagents and other materials 
Exogenous K+ was added as an isotonic physiological salt solution in which all the NaCl was 
replaced with an equivalent amount of KCl. Concentrations of K+ used are expressed as final bath 
concentration. L-NAME (NG-nitro-L-arginine methyl ester), indomethacin, mibefradil, NNC 55-
0396, nifedipine, barium chloride, cesium chloride, ouabain, 4-aminopyridine and papaverine were 
all obtained from Sigma (Poole, U.K.). U46619 (9,11-Dideoxy-11α,9α-epoxymethanoprostaglandin 
F2α) was from Calbiochem (UK). Apamin, charybdotoxin, iberiotoxin and tetrodotoxin from 
Latoxan (Valence, France). SLIGRL (serine-leucine-isoleucine-glycine-arginine-leucine-NH2) 
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from Auspep (Parkville, Australia). TRAM-34 was a generous gift from Dr H. Wulff (University of 
California, Davis). All stock solutions were dissolved in distilled water except SLIGRL and 
charybdotoxin, dissolved in 0.9% NaCl, U46619 and TRAM-34, dissolved in dimethylsulfoxide 
(DMSO), nifedipine, dissolved in ethanol, and indomethacin which was dissolved in Na2CO3 (2%); 
vehicle controls were performed for drugs dissolved in DMSO ethanol and Na2CO3. All 
nomenclature conforms to the BJP guide to receptors and ion channels (Alexander et al., 2008) 
 
3. Results 
 
3.1. Effect of inhibiting Nitric oxide synthase and BKCa on Em and tension. 
Rat middle cerebral arteries developed spontaneous myogenic tone equivalent to 1.3±0.1 mN 
(≈15 % of maximum tension, with 55 mmol/L KCl, n=40) with a resting membrane potential (Em) 
of -42.1±0.9 mV (n=40).  Addition of the NOS inhibitor, L-NAME (100 µM), and the 
cyclooxygenase inhibitor, indomethacin (10 µM) tended to evoke smooth-muscle cell 
depolarization (Em -39.2±1.0 mV, n=38) and constriction (4.6±0.2 mN, n=40; P<0.05). In all 
vessels, the depolarization developed into ongoing oscillations (amplitude 7±0.9 mV) followed by 
equivalent changes in tone (amplitude 0.12±0.01 mN). We have previously reported similar 
observations in the rat middle cerebral artery following NOS inhibition alone (Yuill et al., 2010).  
With L-NAME present, stimulation of the endothelium with 20µM SLIGRL evoked 
hyperpolarization of 20.9±1.7 mV (n=31) associated with 77.6±3.6 % relaxation (n=37). 
 
In the presence of L-NAME and indomethacin, the BKCa channel inhibitor, iberiotoxin (100 nM), 
evoked further depolarization (to Em -35.7±1.1 mV, n=40; P<0.05) and constriction (to 5.7±0.2 mN, 
n=41; P<0.05), associated with a marked increase in the amplitude of oscillations in Em temporally 
linked to tension (Figure 1B). The oscillations in Em and tension had a frequency of 0.84±0.02 Hz 
and 0.80±0.05 Hz and amplitude of 22.6±1.3 mV and 0.19±0.02 mN, respectively (n=41). All 
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subsequent experiments were performed in the presence of L-NAME, indomethacin and iberiotoxin 
unless stated.  Removal of the endothelium abolished SLIGRL-mediated relaxation (20 µM), but 
failed to affect oscillations in Em (frequency of 0.76±0.10 Hz; amplitude of 19.4±4.3 mV) and 
tension (frequency of 0.66±0.10 Hz; amplitude of 0.16±0.05 mN, n=3). 
 
3.2 [Ca2+]o but not Na+ or Cl- currents modify oscillations in membrane potential  
The voltage-dependent Na+ channel blocker, tetrodotoxin (1 µM) did not modify either the 
frequency or amplitude of oscillations in Em (control: frequency of 0.84±0.03 Hz, amplitude of 
16.1±1.4 mV; tetrodotoxin: frequency of 0.90±0.02 Hz, amplitude of 15.4±2.7 mV, n=3) and 
tension (control: frequency of 0.73±0.11 Hz, amplitude of 0.13±0.01 mN; tetrodotoxin: frequency 
of 0.67 ± 0.14 Hz, amplitude of 0.12±0.01 mN, n=3).  
 
To investigate if the oscillations were dependent upon Ca2+ influx, we decreased extracellular Ca2+ 
in steps from 2.5 to 0 mM. Simultaneous measurements of changes in Em and tension showed that 
decreasing Ca2+ evoked depolarization (from -37.0±2.1 to -26.8±2.4 mV, n=7; P<0.05) and 
relaxation (from 5.4±0.6 to 0.3±0.1 mN, n=7; P<0.05). Under these conditions, the amplitude of 
oscillations in Em and tension was diminished (Figure 1C and D).  The calcium-dependent Cl- 
channel inhibitor, DIDS (150 µM), did not alter spontaneous oscillations in Em or tension (data not 
shown) nor did it modify Em (control: -44.4±3.0 mV; DIDS: -49.2±3.9 mV, n=5) or tension 
(control: 4.7±0.6 mN; DIDS: 3.6±0.5 mN, n=5). 
 
3.4. Effect of Ca2+channel blockers on oscillations in Em and tension 
The T-type selective Ca2+ channel blocker, mibefradil (100 nM) abolished oscillations in Em (Figure 
2A), significantly reduced oscillations in tension (control: frequency of 0.79± 0.07 Hz, amplitude of 
0.16±0.04 mN; mibefradil: frequency of 0.09± 0.05 Hz, amplitude of 0.04±0.02 mN, n=5; P<0.05) 
and evoked relaxation (control: 5.1±0.7 mN; mibefradil: 3.5±0.6 mN, n=5) and depolarization (Em 
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control: -36.1±1.3 mV; Em mibefradil: -30.4±2.5 mV, n=5). The more selective T-type Ca2+ channel 
antagonist, NNC 55-0396 (300 nM) also significantly reduced oscillations in Em (Figure 2B) and in 
tension (control: frequency of 0.79± 0.09 Hz, amplitude of 0.17±0.03 mN; NNC 55-0396: 
frequency of 0.20± 0.07 Hz, amplitude of 0.07±0.02 mN, n=6; P<0.05) and evoked relaxation 
(control: 5.5±0.5 mN; NNC 55-0396: 3.0±0.5 mN, n=6; P<0.05). However, NNC 55-0396 did not 
significantly modify mean Em (Em control: -36.2±3.2 mV; Em NNC 55-0396: -31.9±3.2 mV, n=6). 
Further addition of the L-type voltage-gated Ca2+ channel inhibitor, nifedipine (1 µM), relaxed 
(control: 5.8±0.7 mN; NNC 55-0396 3.5 ± 0.6 mN; NNC 55-0396+nifedipine: 0.5±0.1 mN, n=4; 
P<0.05) and hyperpolarized (Em control: -33.0±3.7 mV; Em NNC 55-0396: -30.0 ± 4.6; Em NNC 
55-0396+nifedipine: -36.7±3.4 mV, n=4; Figure 2C).  We also assessed the effect of NNC 55-0396 
against middle cerebral artery basal myogenic tone in the absence of inhibitors. NNC 55-0396 (300 
nM) did not significantly affect Em (Em control: -51.6 ± 2.47; Em NNC 55-0396: -48.9 ± 2.0 mV, 
n=5) or relax myogenic tone (control: 1.04 ± 0.18; NNC 55-0396: 0.69  ±  0.09 mN) under these 
conditions. The additional presence of nifedipine (1 µM) also failed to evoke hyperpolarization (Em 
NNC 55-0396+ nifedipine: -51.5  ±  2.8 mV) but did cause significant relaxation (NNC 55-0396+ 
nifedipine: 0.44 ± 0.04 mN, n=4, P<0.05). We have previously demonstrated similar relaxation of 
basal myogenic tone with nifedipine alone (Yuill et al., 2010).  
 
 
3.5. Involvement of KCa3.1(IKCa)  and KCa2.3(SKCa) channels  
 
Addition of the KCa3.1 channel blocker, TRAM-34 (1 µM) markedly decreased the amplitude of 
oscillations in Em and tension (Figure 3B) followed by small relaxation (control: 6.5±0.4 mN; 
TRAM-34: 5.3±0.2 mN, n=5; P<0.05). TRAM-34 did not significantly reduce Em, (Em control: -
33.9±2.6 mV; Em TRAM-34: -28.7±2.3 mV, n=4). The effect of TRAM-34 on the amplitude of 
oscillations in Em (control: 19.4±4.3 mV; TRAM-34: 3.0±1.6 mV, n=3; P<0.05) and tension 
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(control: 0.16±0.05 mN; TRAM-34: 0.04±0.02 mN, n=3) was similar after endothelium removal. 
The oscillations in Em and tension were not modified by the KCa2.3 blocker apamin (50 nM), either 
alone (Figure 3C) or in the additional presence of TRAM-34 (Figure 3D). Likewise, charybdotoxin 
(100 nM) alone (Figure 4B) or with apamin (Figure 4C) did not affect either oscillations in Em and 
tension (Figure 4D and E), or mean tension and Em.  
 
3.6. Involvement of KIR channels, voltage-gated K+ channels and the Na+/K+-ATPase  
Inhibition of KIR channels with BaCl2 (30 µM) did not affect the amplitude of oscillations in Em 
(control: 31.1±4.6 mV; BaCl2: 30.9±6.1 mV, n=5) or tension (control: 0.20±0.03 mN; Ba2+: 
0.19±0.03 mV, n=5). However, another inhibitor of KIR, CsCl (10 mM) increased the amplitude of 
oscillations in Em (control: 30.8±2.0 mV; CsCl: 40.4±3.4 mV, n=5; P<0.05), but not in tension 
(control: 0.20±0.02 mN; CsCl: 0.19±0.02 mV, n=5), while 4-aminopyridine (4-AP; 3 mM to block 
Kv) increased the amplitude of oscillations in both Em  (control: 17.75±2.07; 4-AP: 30.62±7.33 mV, 
n=3) and tension (control: 0.17±0.01; 4-AP: 0.25 ± 0.07 mN; n=3,  Figure 5A). The Na+/K+-
ATPase inhibitor, ouabain (1 µM) evoked relaxation (control: 5.8±0.3 mN; ouabain: 4.6±0.2 mN, 
n=3; P<0.05) but without significantly reducing Em (control: -42.2±1.2 mV; ouabain: -38.4±1.6 mV, 
n=3). However, ouabain did reduce both the amplitude (Figure 5B and C) and frequency (control: 
0.97±0.11 Hz; ouabain: 0.31±0.16 Hz, n=3; P<0.05) of oscillations in Em, without altering 
oscillations in tension (Figure 5C and frequency control: 1.30±0.22 Hz; plus ouabain: 0.92±0.22 Hz, 
n=3). The subsequent addition of 4-AP in the presence of ouabain caused depolarization (ouabain: -
38.4±1.6 mV; ouabain+4-AP: -34.6±3.3 mV, n=3; P<0.05), and increased oscillations in Em 
(Figure 5C) and increased tension overall (ouabain: 4.6±0.2 mN; ouabain+4-AP: 5.5±0.2 mN, n=3; 
P<0.05). 
 
4. Discussion 
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This study provides the first demonstration, that rhythmic oscillations in membrane potential and 
tension as well as the associated spasm in rat isolated middle cerebral arteries following inhibition 
of BKCa channels and/or NOS reflect Ca2+ influx via T-type Ca2+ channels, in addition to L-type 
Ca2+ channels. These data extend our previous observation that NOS inhibition leads to L-type Ca2+ 
channel opening and arterial spasm, characterized by sustained constriction and superimposed by 
rapid vasomotion (Yuill et al., 2010). Vasomotion was of much higher frequency than previously 
recorded in other vascular beds, and as such we refer to it as ‘vasospastic’ vasomotion. We also 
provide evidence for modulation of both the Ca2+ dependent vasomotion and constriction through 
Na/K ATPase and a K+ conductance.  
 
Consistent with previous work, our data suggest that calcium influx underlies rhythmic oscillations 
in the constricted rat middle cerebral artery, and that oscillations in membrane potential and tension 
are linked to oscillations in intracellular [Ca2+]i as well as spasm in both middle cerebral and basilar 
arteries (Haddock et al., 2002; Navarro-Gonzalez et al., 2009; Yuill et al., 2010). Reducing 
extracellular calcium diminished the amplitude of oscillations, led to relaxation and paradoxically 
depolarized the membrane. The relaxation presumably reflected the reduction in peak Em associated 
with the reduced amplitude of oscillations in Em.  Some small oscillations in tension did persist and 
may reflect vasomotion-independent intracellular calcium release, as reported in some arterial beds: 
for review see Haddock et al., 2005 (Haddock et al., 2005). As oscillations were insensitive to the 
calcium-dependent Cl- channel inhibitor, DIDS and the voltage-dependent Na+ channel blocking 
agent, tetrodotoxin they certainly appeared to be mediated exclusively by calcium conductance. 
These data contrast with the basilar artery, where inhibition of Cl- channels in this larger artery 
abolished calcium-dependent oscillations, leading to hyperpolarization and relaxation (Haddock et 
al., 2002), and parenchymal arterioles, where calcium-dependent oscillations were blocked with 
tetrodotoxin (Filosa et al., 2004). However, our data are consistent with human pial arteries, where 
tetrodotoxin was also without effect against oscillations in diameter (Gokina et al., 1996). In the 
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present study, oscillations in muscle membrane potential were also resistant to direct damage of the 
endothelium, suggesting this monolayer may not influence rapid vasomotion associated with arterial 
spasm.   
 
In the rat middle cerebral artery, opening L-type Ca2+ channels is essential for vasoconstriction and 
vasomotion to develop, because inhibition of these channels abolishes vasomotion and fully 
reverses tone (Yuill et al., 2010). Surprisingly, in the present study under similar vasospastic 
conditions, oscillations in Em, and the associated oscillations in tension were abolished and followed 
by relaxation after calcium influx through T-type Ca2+ channels was blocked with mibefradil (at a 
concentration selective for block of T-type Ca2+ channels; 100 nM) or with a T-type Ca2+ channel 
selective, non-hydrolysable analogue of mibefradil, NNC 55-0396, (Huang et al., 2004). Block of 
oscillations with the putative T-type Ca2+ channel blockers was not associated with a net 
hyperpolarization and complete relaxation, contrasting with the L-Type Ca2+ channel blocker 
nifedipine. So the effect of mibefradil or NNC 55-0396 is unlikely to reflect a non-specific effect 
against L-type channels. Furthermore, although mibefradil apparently reduced blood pressure and 
myogenic tone by an action on L-type calcium channels (Moosmang et al., 2006), the lower 
concentration of mibefradil used in the present study is relatively specific against T-type Ca2+ 
channels. In fact, mibefradil seems only to inhibit the L-type Ca2+ channels after tissue metabolism 
(Wu et al., 2000). The non-hydrolysable analogue of mibefradil NNC 55-0396 is selective for T-
type Ca2+ channels, with no reported block of L-type Ca2+ channels even in concentrations as high 
as 100 µM (Huang et al., 2004).  Mibefradil has also been reported to block both Cl- (Bernd et al., 
1997) and Na+ (Eller et al., 2000; Guatimosim et al., 2001) channels, but again with much higher 
concentrations (µM) than employed in the current study. Furthermore, the fact that blockers such as 
DIDs and TTX had no effect against vasospastic vasomotion makes an action of mibefradil against 
these channels extremely unlikely. Therefore, the differential effect of mibefradil and NNC-0396 
compared to the selective blocker L-type Ca2+ channel blocker nifedipine indicate a critical role for 
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T-type Ca2+ channels in vasospastic vasomotion. Further, these channels contribute significantly to 
overall constriction in the middle cerebral artery.  
 
Vasospastic vasomotion only developed once the smooth muscle cells depolarized to circa -40 mV, 
so it may be that T-type channels involved in vasomotion have gating properties similar to high 
voltage activated Ca2+ channels. This is surprising, as by definition T-type Ca2+ channels activate at 
low potentials and then quickly inactivate (Lacinova, 2005). However, our data are consistent with 
studies reporting T-type Ca2+ channels that influence vascular tone and have properties similar to 
high-voltage activated Ca2+ channels, (Navarro-Gonzalez et al., 2009). Both T- and L-type Ca2+ 
channels are expressed in rat basilar (Navarro-Gonzalez et al., 2009) and middle cerebral arteries 
(Kuo et al., 2008), and in each artery the CaV3.2 (or T-type) is the most abundant VGCC alpha 
subunit expressed. Human recombinant T-type Ca2+ channels (Kaku et al., 2003) and T-type Ca2+ 
channels co-expressed with auxiliary subunits (Wyatt et al., 1998) do have gating properties similar 
to high voltage activated channels, so channels in the middle cerebral artery may be similar. 
Peripheral arteries also contain VGCCs with similar biophysical properties to high voltage activated 
channels (-50 to -20 mV), and are pharmacologically indistinguishable from T-type Ca2+ channels 
in both the guinea–pig and rat (Morita et al., 1999; Morita et al., 2002). In these small mesenteric 
arteries, T-type Ca2+ channels are the predominant voltage-gated subtype (Gustafsson et al., 2001; 
Jensen et al., 2004), and show increased window current due to non-inactivation at physiological Em  
(Jensen et al., 2009).    
 
As nifedipine abolished vasomotion, we propose that L-type channels are key for the initial 
depolarization and constriction (Yuill et al., 2010); whereas T-type are activated subsequently and 
as such are critical for the vasospastic vasomotion. Interestingly, input from T-type Ca2+ channels 
seem to be important for the initial constriction in the basilar artery, whereas L-type channels are 
critical for vasomotion (Navarro-Gonzalez et al., 2009). But taken together, these results all suggest 
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a functional coupling between L- and T-type Ca2+ channels, as previously suggested in renal 
(Hansen et al., 2001) and mesenteric arterioles (Braunstein et al., 2008). As such, this might explain 
why neuroprotection in ischemic stroke is more effective in patients given blockers for more than 
just  L-type VGCCs (Kobayashi et al., 1998).  
  
As VGCC and hence vasospastic vasomotion are inhibited by a complex interaction between NO 
and smooth muscle cell BKCa channels in middle cerebral arteries, we attempted to characterise 
further the vasospastic vasomotion. Endothelial cell damage did not affect the vasomotion, so we 
inhibited a variety of K+ currents. Both inwardly rectifying and voltage-gated K+ channels 
participate in maintenance of resting membrane potential and vascular tone (Ko et al., 2008; Nelson 
et al., 1995; Sobey, 2001). However, inhibition of KIR channels with CsCl or barium did not affect 
vascular tone, although CsCl did slightly increase Em oscillation amplitude. As Ba2+ was without 
effect, this small change most likely reflected a non-selective action of CsCl. Inhibition of Kv 
channels with 4-AP also had little effect, causing only a small increase in the amplitude of 
oscillations in Em and tension. This is consistent with the reported role of these channels in rat 
mesenteric artery where inhibition of Kv increased rhythmic contractions (Gustafsson et al., 1994). 
So voltage-gated K+ channels did not appear to play any major role in vasospastic vasomotion.  
 
Our data do suggest that Na+/K+-ATPase might contribute to vasomotion, as ouabain caused 
relaxation and reduced the amplitude and frequency of oscillations in Em, although surprisingly 
without affecting oscillations in tension. Ouabain can attenuate intercellular communication in 
smooth muscle (Harris et al., 2000; Martin et al., 2003; Matchkov et al., 2007) and the 
synchronized changes in vascular [Ca2+]i (Koenigsberger et al., 2004) that lead to vasomotion 
(Chaytor et al., 1997; Matchkov et al., 2004; Peng et al., 2001). So in part, ouabain may alter 
membrane potential oscillations by modifying cell-cell communication. Interestingly, ouabain 
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effects were reversed by 4-AP, again indicating that KV might contribute under some conditions to 
influence vasomotion. 
 
The ability of the KCa3.1 channel inhibitor TRAM-34 to reduce rather than enhance the amplitude 
of oscillations in Em and tension was also unexpected. This effect was on the smooth muscle, as it 
was not altered by removal of the endothelium, and in contrast to TRAM-34, charybdotoxin, a 
mixed BKCa and KCa3.1 inhibitor failed to modify the oscillations. One explanation, is that TRAM-
34 inhibits non-selective cation channels in the smooth muscle, similar to its action in isolated 
immune cells (Schilling et al., 2007). Non-selective cation channels are present in rat middle 
cerebral artery smooth muscle cells and appear to contribute to the calcium entry and vascular tone 
(Marrelli et al., 2007; Welsh et al., 2002). So data with TRAM-34 suggest that non-selective cation 
channels may play an important role in the calcium entry events underpinning depolarization and 
vasomotion after NOS inhibition in the middle cerebral artery.  
 
In summary, inhibition of either BKCa channels and/or NOS evokes vasospasm and fast, rhythmic 
oscillations in Em and tension that are mediated by Ca2+ influx via both T-type and L-type Ca2+ 
channels. Our data suggest the T-type channels are active at physiologically relevant membrane 
potentials and can therefore make an important contribution to the control of cerebrovascular blood 
flow during vasospasm associated with disease states where NO synthesis or action is impaired, 
such as cerebral ischemia or subarachnoid haemorrhage.      
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Figure Legends 
 
Figure 1. Original traces showing simultaneous recordings of membrane potential (upper panels) 
and tension (lower panels) in rat middle cerebral arteries under control resting conditions (A) or in 
the presence of L-NAME (100 μM), indomethacin (10 μM) and iberiotoxin (100 mN; B). Under 
control conditions, membrane potential and tension are relatively stable. In the presence of L-
NAME, indomethacin and iberiotoxin, the smooth muscle cells depolarized and developed regular 
depolarizing oscillations, which were associated with constriction and oscillations in tension; the 
peaks in membrane potential immediately preceded peaks in tension.  Decreasing extracellular 
calcium (from 2.5 to 0 mM Ca2+) caused depolarization and relaxation. Average data are shown in 
(C and D) showing the oscillation amplitude in membrane potential (C) and tension (D) in control 
vessels (2.5 mM Ca2+) and in the presence of 1, 0.5, 0.25 and 0 mM Ca2+. Data expressed as means 
± S.E.M. * P≤0.05 indicates a significant difference from control by one-way ANOVA with 
Tukey’s post-hoc test, n=3-7.  
 
Figure 2. Original traces showing the effect of either (A) the T-type Ca2+ channel blocker, 
mibefradil (100 nM), (B) the more selective T-type Ca2+ channel antagonist, NNC 55-0396 (300 
nM) or (C) the combined application of NNC 55-0396 (300 nM) and the L-type Ca2+ channel 
blocker, nifedipine (1 µM), on simultaneous recordings of membrane potential (upper panels) and 
tension (lower panels). Both mibefradil and NNC 55-0396 caused relaxation and abolished 
oscillations in membrane potential and tension; combined application of NNC 55-0396 and 
nifedipine caused greater hyperpolarization and relaxation than NNC-550396 alone, n=4-6. Parallel 
lines (//) indicate a time break between same recordings from a single vessel the first time break 
shows the response at approximately 5 min post addition of drug the second time break corresponds 
to the maximum response which is approximately 15 min following addition . 
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Figure 3. Original traces showing control conditions (A), the effect of the KCa3.1 channel blocker, 
TRAM-34 (1 μM; B), the KCa2.3 channel blocker, apamin (50 nM; C) or the combined application 
of TRAM-34 and apamin (D) on simultaneous recordings of membrane potential (upper panels) and 
tension (lower panels). Average data for oscillation amplitude in membrane potential (left panel) 
and tension (right panel) in control vessels and in the presence of TRAM-34, apamin and TRAM-34 
+ apamin are also shown (E). Data are expressed as means ± S.E.M. * P≤0.05 indicates a significant 
difference from control by one-way ANOVA with Tukey’s post-hoc test, n=3-9. 
 
Figure 4. Original traces showing control conditions (A) and the effect of either the BKCa and 
KCa3.1 channel blocker, charybdotoxin  (100 nM; B) or the combined application of charybdotoxin  
(100 nM) and the KCa2.3 channel blocker, apamin (50 nM; C) on simultaneous recordings of 
membrane potential (upper panels) and tension (lower panels). Average data are shown for the 
oscillation amplitude in membrane potential (D) and tension (E) in control vessels and in the 
presence of charybdotoxin and charybdotoxin + apamin. Data expressed as means ± S.E.M. n=3-4. 
 
Figure 5. Original traces showing (A) the effect of the voltage-gated K+channel inhibitor, 4-AP (3 
mM) and (B) the effect of the Na+/K+-ATPase inhibitor, ouabain (1 µM) on simultaneous 
recordings of membrane potential (upper panels) and tension (lower panels). Average data are 
shown in (C) showing the oscillation amplitude in membrane potential (left panel) and tension 
(right panel) in control vessels and in the presence of ouabain and ouabain + 4-AP. Data expressed 
as means ± S.E.M. */+ P≤0.05 indicates a significant difference from either control or from ouabain 
alone, respectively, using one-way ANOVA with Tukeys post-hoc test, n=3. 
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